Westfield Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,310,336
| Closed | -$52.7M | – | 250 |
|
|
2025
Q1 | $52.7M | Buy |
1,310,336
+30,346
| +2% | +$1.22M | 0.26% | 121 |
|
|
2024
Q4 | $60.2M | Buy |
1,279,990
+67,104
| +6% | +$3.16M | 0.26% | 121 |
|
|
2024
Q3 | $64M | Buy |
1,212,886
+339,373
| +39% | +$17.9M | 0.29% | 113 |
|
|
2024
Q2 | $47.3M | Buy |
873,513
+142,127
| +19% | +$7.7M | 0.23% | 138 |
|
|
2024
Q1 | $51.3M | Buy |
+731,386
| New | +$51.3M | 0.27% | 133 |
|